{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:21:08Z","timestamp":1789665668538,"version":"4.0.1"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2009,5,25]],"date-time":"2009-05-25T00:00:00Z","timestamp":1243209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Apelin, a novel peptide with a putative role in cardiovascular homeostasis, has gained interest as an endogenous inotrope, but has yet to be described following acute myocardial infarction (AMI) in man. We aimed to characterize plasma apelin concentrations following AMI and to examine its relationship with clinical and prognostic biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Plasma concentrations of apelin, N-terminal probrain natriuretic peptide (NT-proBNP), norepinephrine, and arginine vasopressin were measured in 100 patients [mean age 58.9 \u00b1 12 (SD) years, 77% male] admitted with AMI, with echocardiographic left ventricular (LV) ejection fraction &amp;lt;40%, at mean 46 h after admission and at 24 weeks. Cardiac magnetic resonance imaging was performed pre-discharge and at 24 weeks. Thirty-eight subjects with no cardiac history acted as controls. Apelin concentration was reduced early after AMI (0.54 \u00b1 0.25 vs. 3.22 \u00b1 3.01 ng\/mL, P &amp;lt;0.001) and remained low at 24 weeks, although it did increase significantly from baseline to 0.62 \u00b1 0.36 ng\/mL, P = 0.030. Apelin had no relationship with any parameter of LV function over time. A relationship was found between baseline apelin and norepinephrine (r = 0.26, P = 0.008). Both NT-proBNP and norepinephrine correlated with adverse ventricular function after AMI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Plasma apelin concentration is reduced early after AMI, increases significantly over time, but remains depressed at 24 weeks.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjhf\/hfp043","type":"journal-article","created":{"date-parts":[[2009,4,7]],"date-time":"2009-04-07T21:30:51Z","timestamp":1239139851000},"page":"551-558","source":"Crossref","is-referenced-by-count":70,"title":["Plasma Apelin Concentration is Depressed Following Acute Myocardial Infarction in Man"],"prefix":"10.1093","volume":"11","author":[{"given":"Robin A.P.","family":"Weir","sequence":"first","affiliation":[{"name":"Cardiology Department, Western Infirmary , Glasgow, G11 6NT, Scotland ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok Shiong","family":"Chong","sequence":"additional","affiliation":[{"name":"Cardiology Department, Western Infirmary , Glasgow, G11 6NT, Scotland ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Dalzell","sequence":"additional","affiliation":[{"name":"Cardiology Department, Western Infirmary , Glasgow, G11 6NT, Scotland ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin J.","family":"Petrie","sequence":"additional","affiliation":[{"name":"Cardiology Department, Western Infirmary , Glasgow, G11 6NT, Scotland ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Cardiology Department, Western Infirmary , Glasgow, G11 6NT, Scotland ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Steedman","sequence":"additional","affiliation":[{"name":"Cardiology Department, Western Infirmary , Glasgow, G11 6NT, Scotland ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick B.","family":"Mark","sequence":"additional","affiliation":[{"name":"Cardiology Department, Western Infirmary , Glasgow, G11 6NT, Scotland ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa A.","family":"McDonagh","sequence":"additional","affiliation":[{"name":"Cardiology Department, Royal Brompton Hospital , London, SW3 6NP ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry J.","family":"Dargie","sequence":"additional","affiliation":[{"name":"Cardiology Department, Western Infirmary , Glasgow, G11 6NT, Scotland ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.V.","family":"McMurray","sequence":"additional","affiliation":[{"name":"Cardiology Department, Western Infirmary , Glasgow, G11 6NT, Scotland ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,5,25]]},"reference":[{"key":"2026020203402737800_ejhfhfp043-bib-0001","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","article-title":"Isolation and charcaterization of a novel endogenous peptide ligand for the human APJ receptor","volume":"251","author":"Tatemoto","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"2026020203402737800_ejhfhfp043-bib-0002","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0165-6147(02)00007-X","article-title":"Emerging roles for orphan G-protein-coupled receptors in the cardiovascular system","volume":"24","author":"Katugampola","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"2026020203402737800_ejhfhfp043-bib-0003","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.regpep.2004.10.019","article-title":"Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells","volume":"126","author":"Kleinz","year":"2005","journal-title":"Regul Pept"},{"key":"2026020203402737800_ejhfhfp043-bib-0004","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.regpep.2003.11.002","article-title":"Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells","volume":"118","author":"Kleinz","year":"2004","journal-title":"Regul Pept"},{"key":"2026020203402737800_ejhfhfp043-bib-0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0167-0115(01)00236-1","article-title":"The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism","volume":"99","author":"Tatemoto","year":"2001","journal-title":"Regul Pept"},{"key":"2026020203402737800_ejhfhfp043-bib-0006","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.bbrc.2007.04.017","article-title":"Direct effects of apelin on cardiomyocyte contractility and electrophysiology","volume":"357","author":"Farkasfalvi","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"2026020203402737800_ejhfhfp043-bib-0007","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejphar.2006.09.034","article-title":"Apelin increases contractility in failing cardiac muscle","volume":"553","author":"Dai","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"2026020203402737800_ejhfhfp043-bib-0008","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.RES.0000033522.37861.69","article-title":"Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility","volume":"91","author":"Szokodi","year":"2002","journal-title":"Circ Res"},{"key":"2026020203402737800_ejhfhfp043-bib-0009","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jacc.2008.06.013","article-title":"Vascular effects of apelin in vivo in man","volume":"52","author":"Japp","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026020203402737800_ejhfhfp043-bib-0010","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jacc.2006.03.061","article-title":"Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure","volume":"48","author":"van Kimmenade","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026020203402737800_ejhfhfp043-bib-0011","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.regpep.2006.12.004","article-title":"Utility of plasma apelin and other indices of cardiac dysfunction in the clinical assessment of patients with dilated cardiomyopathy","volume":"140","author":"Miettinen","year":"2007","journal-title":"Regul Pept"},{"key":"2026020203402737800_ejhfhfp043-bib-0012","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0006-291X(03)01424-4","article-title":"Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure","volume":"308","author":"Foldes","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"2026020203402737800_ejhfhfp043-bib-0013","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ejheart.2005.10.007","article-title":"Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure","volume":"8","author":"Chong","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"2026020203402737800_ejhfhfp043-bib-0014","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejheart.2006.06.005","article-title":"Cardiac resynchronization therapy increases plasma levels of the endogenous inotrope apelin","volume":"9","author":"Francia","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"2026020203402737800_ejhfhfp043-bib-0015","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/01.CIR.0000091235.94914.75","article-title":"Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction","volume":"108","author":"Chen","year":"2003","journal-title":"Circulation"},{"key":"2026020203402737800_ejhfhfp043-bib-0016","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/hrt.2003.015552","article-title":"Effects of carvedilol on left ventricular remodelling in chronic stable heart failure: a cardiovascular magnetic resonance study","volume":"90","author":"Bellenger","year":"2004","journal-title":"Heart"},{"key":"2026020203402737800_ejhfhfp043-bib-0017","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.CIR.76.1.44","article-title":"Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction","volume":"76","author":"White","year":"1987","journal-title":"Circulation"},{"key":"2026020203402737800_ejhfhfp043-bib-0018","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.yjmcc.2006.07.004","article-title":"Down-regulation of cardiac apelin system in hypertrophied and failing hearts: possible role of angiotensin II\u2013angiotensin type 1 receptor system","volume":"41","author":"Iwanaga","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"2026020203402737800_ejhfhfp043-bib-0019","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1161\/CIRCRESAHA.107.158659","article-title":"Impaired heart contractility in apelin gene-deficient mice associated with aging and pressure overload","volume":"101","author":"Kuba","year":"2007","journal-title":"Circ Res"},{"key":"2026020203402737800_ejhfhfp043-bib-0020","doi-asserted-by":"crossref","first-page":"II187","DOI":"10.1161\/01.CIR.0000138382.57325.5c","article-title":"Apelin has in vivo inotropic effects on normal and failing hearts","volume":"110","author":"Berry","year":"2004","journal-title":"Circulation"},{"key":"2026020203402737800_ejhfhfp043-bib-0021","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cardiores.2004.08.018","article-title":"The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo","volume":"65","author":"Ashley","year":"2005","journal-title":"Cardiovasc Res"},{"key":"2026020203402737800_ejhfhfp043-bib-0022","doi-asserted-by":"crossref","first-page":"H88","DOI":"10.1152\/ajpheart.00935.2007","article-title":"In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure","volume":"294","author":"Sheikh","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026020203402737800_ejhfhfp043-bib-0023","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1161\/01.CIR.0000041661.63285.AE","article-title":"N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes","volume":"106","author":"Omland","year":"2002","journal-title":"Circulation"},{"key":"2026020203402737800_ejhfhfp043-bib-0024","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cardfail.2007.07.006","article-title":"Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function","volume":"13","author":"Orn","year":"2007","journal-title":"J Card Fail"},{"key":"2026020203402737800_ejhfhfp043-bib-0025","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.amjcard.2004.10.034","article-title":"Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction","volume":"95","author":"Ndrepepa","year":"2005","journal-title":"Am J Cardiol"},{"key":"2026020203402737800_ejhfhfp043-bib-0026","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1067\/mhj.2001.119612","article-title":"Changes in vasoconstrictive hormones, natriuretic peptides, and left ventricular remodeling soon after anterior myocardial infarction","volume":"142","author":"White","year":"2001","journal-title":"Am Heart J"},{"key":"2026020203402737800_ejhfhfp043-bib-0027","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1359-6101(96)00043-3","article-title":"Stress activated cytokines and the heart","volume":"7","author":"Mann","year":"1996","journal-title":"Cytokine Growth Factor Rev"},{"key":"2026020203402737800_ejhfhfp043-bib-0028","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1093%2Feurjhf%2Fhfp043","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1093%2Feurjhf%2Fhfp043","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1093\/eurjhf\/hfp043","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1093\/eurjhf\/hfp043","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/11\/6\/551\/66547577\/eurjhf_11_6_551.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/11\/6\/551\/66547577\/eurjhf_11_6_551.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T08:40:34Z","timestamp":1770021634000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/11\/6\/551\/8439041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,25]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2009,5,25]]},"published-print":{"date-parts":[[2009,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjhf\/hfp043","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2009,6]]},"published":{"date-parts":[[2009,5,25]]}}}